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1. Introduction 
Evidence supporting the roles played by phospho- 
lipase Az or phospholipase C and diglyceride-lipase in 
the release of arachidonic acid have been reviewed in 
[ 13. The precise mechanism, however, remains open 
to controversy. There is general agreement hat throm- 
boxanes are formed from arachidonic acid released 
from the membrane phospholipids in thrombin-stim- 
ulated platelets. Furthermore, apparently selective 
phospholipase Az inhibitors such as mepacrine, 
bromophenacylbromide and CB 874 inhibit aggrega- 
tion in human, rabbit and guinea-pig platelets [2,3]. 
The exclusive action of these phospholipase Az inhib- 
itors nevertheless remains questionable since they act 
also as amphiphilic membrane-active agents [ 11. The 
release of arachidonic acid by the phospholipase C 
pathway is an alternative to the direct action of phos- 
pholipase Az and is supported by the apparent accu- 
mulation of diglycerides during platelet activation 
[4,51. 
the membrane lipid domain described. We have suc- 
ceeded in incorporating parinaric acid into the phos- 
pholipids of platelet membranes and we describe the 
use of these labelled preparations to provide informa- 
tion about the mechanism of deacylation in the plate- 
let aggregation reaction. 
2. Materials and methods 
2.1. Incorporation of a&transparinaric acid into the 
platelet lipids 
A sensitive assay of phospholipase Az activity in 
venom of Crotalus adamanteus has been developed 
using the fluorescent substrate 2-parinoyl-lecithin [6]. 
The deacylation of the lecithin was monitored by the 
release and binding of the free parinaric acid to albu- 
min recorded as an increase in fluorescence polariza- 
tion (p> as the physical environment of the fluorophore 
changed. The sensitivity of the assay (-1 nmol/min) 
and its adaptability to provide continuous measure- 
ment of phospholipid deacylation allows us to study 
the phospholipase reaction associated with platelet 
aggregation. 
Fresh, titrated platelet-rich plasma was incubated 
at 37°C under a COz-rich atmosphere with 10 /-d/ml 
of all-trans parinaric acid, 9,11,13,15-octadecatetra- 
enoic acid in the all-trans configuration (Molecular 
Probes Inc., Texas), in ethanol (30 mM). The incuba- 
tion medium was shaken gently at intervals during 
2-3 h incubation. The thrombin-induced aggregation 
of labelled platelets was challenged with control plate- 
lets incubated for the same time without parinaric 
acid. No difference was detectable when parinaric 
acid remained at <0.4-0.5 mM. The presence of 
aspirin (1 mM) did not alter the extent of incorpora- 
tion of parinaric acid into membrane phospholipids. 
The lipids of the labelled platelets were extracted [8] 
and purified by thin-layer chromatography [9] and 
assayed for their parinoyl moiety by fluorescence 
measurements. 
The incorporation of parinaric acid into phospho- 
lipids has been reported in Escherichia coli [7] and 
its use as a fluorescent probe of the physical state of 
Oxidation of the highly unsaturated fluorescent 
parinaric acid was minimised by including 100 ppm 
(w/v) butylhydroxytoluene in all solvents and handling 
extracts in an inert atmosphere. Some parinaric acid 
(1 l-17%) was incorporated into the triglyceride frac- 
tion, (13-18%) into phosphatidylethanolamines, 
(54-76%) into phosphatidylcholines and (0- 11%) 
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into phosphatidylserine t phosphatidylinositol. The 
hydrolysis of a sample of the phosphatidylcholine 
fraction by Crotalus adamanteus phospholipase AZ 
[lo] showed that 68% of the fluorescent fatty acid 
was located at carbon atom 2 of the glycerol moiety. 
2.2. Fluorescence measurements 
The device for measuring fluorescence polarization 
(P) has been described in 161. To examine the platelet 
system the incubation medium was continuously stirred 
by a magnetic bar in the cuvette which wassiliconized 
each day. The fluorescence background (albumin-rich 
Tyrode buffer t unlabelled platelets), light scattering 
and an instrumental correction factor G [ 1 l] were 
taken into account in the calculation of the fluores- 
cence polarization. Photobleaching of the probe was 
reduced by using low illumination. Fluorescence life- 
time measurements were performed with a single- 
photon counting device (Applied Photophysic-Ortec). 
2.3. Incubation conditions for assay of released 
parinurik acid and aggregometry 
The fluorescent labelled platelets were extempora- 
neously washed out from the excess of unincorporated 
parinaric acid by dilution and centrifugation in a large 
volume of 1% albumin-rich Tyrode buffer. The 
washed platelets were gently resuspended in 0.5 ml 
albumin-rich Tyrode and further diluted with albu- 
min-rich Tyrode containing 0.33 mM CaCl,. The 
suspension was stirred at 37°C in a thermostatted 
cuvette in the spectrofluorometer. After equilibration 
for 3-5 min the platelets were activated by addition 
of thrombin (81 NIH-U/mg, Roche, Switzerland). 
The intensity of fluorescence at 420 nm polarized 
parallel (Ill) and perpendicular (IQ) to the polarized 
excitation beam at 320 nm were recorded continu- 
ously. The aggregometric tests were performed in the 
same way and the scattered light (in contrast to light 
transmission as measured by most aggregometers) was 
recorded by setting both of the monochromators of 
the spectrofluorometer at 600 nm. 
3. Results 
The release of parinaric acid from phospholipids of 
the platelet membrane can be monitored conveniently 
by a fluorescence hyperpolarization originating from 
a change in the probe environment from the platelet 
membrane to a tight hydrophobic binding site on the 
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Fig.1. Hyperpolarization of fluorescence resulting in transfer 
of parinaric acid from platelet membranes to albumin-binding 
sites. Parinaric acid (60 nmol) was added to lo9 platelets 
stirred in Tyrode (3 ml) at 37°C. The indicated amounts 
(w/v) of fatty acid free albumin are added and the fluores- 
cence polarization and the total fluorescence intensity are 
determined. The bars indicate 1 SD. 
albumin. This effect is illustrated in fig.1 which shows 
a decrease in total fluorescence and a fluorescence 
hyperpolarization in proportion to the amount of 
defatted albumin added to a suspension of platelets 
containing exogenous parinaric acid. The fluorescence 
changes on binding of parinaric acid to the albumin 
are associated with a reduction in fluorescent lifetime 
from 11.6 ns in the platelet membrane to 3.8 ns when 
bound to albumin. Furthermore, binding of parinaric 
acid to albumin has been confirmed by an observed 
fluorescence energy transfer with a tryptophanoyl 
residue of the protein [12,13]. Studies of the time- 
course of binding of the free parinaric acid to the 
albumin showed that with addition of 0.25% (w/v) 
albumin representing a 2-fold excess of parinaric acid 
binding sites (calculated from [ 12]), binding equilib- 
rium was achieved within 20 s. Additional hyperpo- 
Volume 135, number 2 FEBS LETTERS December 1981 
larization to an apparent maximum value was observed 
on adding 0.5% (w/v) albumin to the suspension. 
Higher concentrations of albumin were avoided to 
maintain a relatively low fluorescence background 
and avoid effects on arachidonic metabolism [ 141 
despite the possibility that some parinaric acid may 
remain bound to the membrane. Additional experi- 
ments were undertaken to examine the release of 
parinaric acid acylated from platelet membrane lipids 
by incubating labelled platelet preparations (pre- 
heated for 15 min at 100°C with 2 mM EDTA) in the 
presence of phospholipase AZ from Crotalus adamen- 
tats venom. There was a gradual increase in fluores- 
cence polarization during incubation over 1 h in 
Tyrode solution @H 8) containing 10 mM CaClz and 
1% (w/v) defatted albumin. The change in fluorescence 
after this period represented a 9% increase in the 
polarization value. 
The time-course of release of parinaric acid was 
investigated in thrombin-activated platelets in the 
presence of different concentrations of defatted albu- 
min. The results (fig.2) show a sigmoidal response to 
o+ t 5 10 lhrombin limqmin 
Fig.2. Influence of albumin level on kinetics of parinaric acid 
release. The fluorescence polarization is recorded as a func- 
tion of time after the addition of thrombin to the fluores- 
cence-labelled platelets suspension stirred in Tyrode buffer 
enriched with: 0.5% (o), 0.2% (m), 0.1% (*) or 0.0% albumin 
(A). 
stimulation by thrombin reaching an apparent maxi- 
mum after 10 min when 0.5% or 0.2% (w/v) albumin 
is present in the suspending medium. The response to 
thrombin stimulation isnot as clear when the albumin 
concentration isreduced to 0.1% (w/v) and cannot be 
detected in the absence of albumin. This is consistent 
with previous observations of the hydrolysis of 
2-parinoyl-lecithin by phospholipase AZ which could 
not be detected in the absence of albumin in the 
medium. 
The concentration of platelets appears to influence 
the extent of the fluorescence hyperpolarization 
(fig.3). Platelet counts of the rats used in these xperi- 
ments were 1.2-l .5 X 106/mm3 and the platelet-rich 
plasma was diluted prior to assay. Fig.3 shows that 
with platelet concentrations in the range 850 OOO- 
400 000/mm3 there are no significant changes in the 
response to thrombin. At the lowest concentration 
(286 000/mm3) the response as observed by fluores- 
cence hyperpolarization is considerably slower and 
reduced. Similar esults were obtained with the aggre- 
gometric tests. Experiments with more diluted plate- 
lets suspensions (-200 000/mm3) were undertaken 
but the reliability of the data was doubtful because of 
the low fluorescence signal and lack of sensitivity of 
the aggregometric test. Finally, the role of phospho- 
lipase A2 activity in platelet response to thrombin 
was examined by observing the effect of the enzyme 
inhibitor bromophenacylbromide. A preincubation of 
platelets for 1 mm in the presence of 0.64 mM or 
0.16 mM causes an increase in response-time of aggre- 
gation after addition of thrombin (figAA) and of 
fluorescence polarization (figAB). The extent of 
fluorescence polarization is decreased by the inhibitor, 
Fig.3. Influence of platelet count on hyperpolarlzation. The 
fluorescence polarization is recorded as a function of time 
after the addition of thrombin (0.33 U/ml) to various diluted 
platelet suspensions in 0.5% albumin-rich Tyrode (3.5 ml): 
(a) 855 000/mm3; (0) 410 OOO/mm’; (A) 286 000/mm3. 
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suggesting that less free parinaric acid is formed. It is 
noticeable that at the highest concentration used 
(0.64 mM) bromophenacylbromide blocks the release 
of the parinaric acid but that the platelet aggregation 
remains still possible. 
5. ‘10 Tlnr, min 
Fig.4. Influence of bromophenacylbromide on hyperpolariza- 
tion and aggregation of platelets. (A) Fluorescence polariza- 
tion is recorded after the addition of thrombin (0.33 U/ml) 
to the fluorescence-labelled platelets uspension in the absence 
(0) or presence of bromophenacylbromide added and stirred 
1 min before the aggregating agent in the cuvette: (A) 
1.6 X lo-’ M; (=) 6.4 X 10e4 M. (B) The corresponding 
aggregometric curves are displayed under the same conditions. 
The light-scattering is recorded at 600 nm for the platelets 
suspension in the absence (0) or presence of bromophenacyl- 
bromide added as before: (A) 1.6 x I O-4 M;(m) 6.4 X lo-’ M. 
4. Discussion 
It has been shown that activation of platelets 
results in the release of free fatty acids, and predomi- 
nantly arachidonic acid from the glycerophosphatides 
of the platelet membrane. We have shown that the 
hyperpolarization of parinaric acid acylated to phos- 
pholipids of the membrane provides a useful method 
of monitoring processes associated with platelet acti- 
vation. It is not possible, with the present method, 
however, to distinguish the two different pathways 
associated with fatty acid release from the membrane 
phospholipids. These are the activation of phospho- 
lipase A2 which hydrolyses fatty acyl residues in the 
carbon 2 position of phosphatidylcholine and phos- 
phatidylethanolamine [ 15 ,161 and secondly a pathway 
involving phospholipase C initially acting on phospha- 
tidylinositol [4,5]. Then a subsequent action of a 
diglyceride-lipase [4] or of a phosphatidic acid specific 
phospholipase AZ [ 171 achieves the release of 
arachidonic acid. 
Some evidence suggests that the phospholipase AZ 
pathway is the preferential route of parinaric acid 
release. Thus the amount of parinaric acid incorpo- 
rated into phosphatidylcholine and phosphatidyl- 
ethanolamine (67-94%) is considerably greater than 
that incorporated into phosphatidylinositol (O- 11%) 
which is the specific substrate of the phospholipase 
C-type enzyme. More parinaric acid is released during 
platelet activation than could be accounted for by 
release from phosphatidylinositol alone. Deacylation 
from the carbon-2 position of phospholipids, however, 
cannot be established unequivocally from the present 
experiments. In the fluorescence labelling process 
83-89% of the parinaric acid becomes incorporated 
into the membrane glycerophosphatides and of this, 
for example, 68% is located in carbon-2 position of 
lecithin and the remainder in carbon-l. Fluorescence 
hyperpolarization can also occur if 1 -parinoyl-lyso- 
phosphatidylcholine is produced by the action of 
phospholipase AZ since the lysophosphatide can bind 
strongly to albumin with consequent fluorescence 
changes [ 181. 
Although the inhibition of parinaric acid release 
from stimulated platelets by bromophenacylbromide 
clearly points to an involvement of phospholipase AZ 
in the platelet activation process its role in aggregation 
may not be as direct as is often assumed [ 171. It may 
be, however, that there are some species differences 
in the processes of platelet activation and there is 
288 
Volume 135, number 2 FEBS LETTERS December 198 1 
some evidence that rat platelets have distinctive 
metabolic responses to the phospholipase AZ-released 
arachidonic acid [ 191. A special activator factor of 
phospholipase AZ in rat platelets has also been identi- 
fied [20]. Another factor that could influence the 
mode of release of free fatty acid from the membrane 
is the concentration of thrombin used to trigger plate- 
let aggregation (C. B., unpublished). We have found 
in preliminary experiments using 1 - [ 14C] arachidonic 
acid labelled platelet membrane phosphoglycerides a 
sharp increase in the radiolabelled diglyceride fraction 
of lipid extracts from platelets 30 s after stimulation 
with 0.8 U/ml of thrombin. This accumulation of 
diglyceride suggests aprimary role for phospholipase C 
acting on arachidonate-containing phospholipids. It is 
our conclusion that both phospholipases AZ and C are 
activated in rat platelets exposed to thrombin and 
that release of parinaric acid from fluorescence-labelled 
platelets takes place in a progressive manner in con- 
trast to the rapid formation of diglyceride by the 
action of phospholipase C. 
Acknowledgements 
Drs M. Vincent and J. Galley are thanked for assis- 
tance in calculating fluorescence lifetimes. A stimu- 
lating discussion with Dr B. B. Vargaftig and the 
cooperation of Dr P. Quinn are gratefully acknowl- 
edged. This work was supported by NATO and DRET. 
References 
[1‘] Vargaftig, B. B., Chignard, M. and Benveniste, J. (1981) 
Biochem. Pharmacol. 30,263-271. 
[2] Vargaftig, B. B. (1977) J. Pharm. Pharmac. 29,222. 
[ 31 VaBee, E., Gougat, J., Navarro, J. and Delahayes, J. F. 
(1979) J. Pharm. Pharmac. 31,588. 
[4] Mauco, G., Chap, H. and Douste-Blazy, L. (1979) 
FEBS Lett. 100,367-370. 
[5] Lapetina, E. G. and Cuatrecasas, P. (1979) Biochim. 
Biophys. Acta 573, 394. 
[6] Wolf, C., Sagaert, L. and Bereziat, G. (1981) Biochem. 
Biophys. Res. Commun. 99, 275-283. 
[7] Tecoma, E. S., Sklar, L. A., Simoni, R. D. and Hudson, 
B. S. (1977) Biochem. 16,829-835. 
[8] Bligh, E. G. and Dyer, W. J. (1959) Can. J. Biochem. 
Physiol. 37,911. 
[9] Lepage, M. (1964) J. Lipid Res. 5,587. 
[lo] Hanahan, D. J. (1959) in: Lipid Chemistry, Wiley, 
New York. 
[ 1 l] Azumi, T. and McGlynn, S. P. (1962) J. Chem. Phys. 
37,2413-2416. 
[ 121 Sklar, L. A., Hudson, B. S. and Simoni, R. D. (1977) 
Biochemistry 16,5100-5108. 
[ 131 Berde, C. B., Hudson, B. S., Simoni, R. D. and Sklar, 
L. A. (1979) J. Biol. Chem. 254,391-400. 
[ 141 Yoshida, N. and Aoki, N. (1978) Blood 52,969-977. 
[15] Bills,T. K., Smith, J. B. and Silver, M. J. (1976) 
Biochim. Biophys. Acta 424, 303. 
[ 161 Rittenhouse-Simmons, S., Russel, F. A. and Deykin, D. 
(1977) Biochim. Biophys. Acta 488, 370. 
[ 171 BiBah, M. M., Lapetina, E. G. and Cuatrecasas, P. 
(1981) J. Biol. Chem. 256,5399-5404. 
[ 181 Barlow, W. M. and Klopfenstein, W. E. (1980) Biochim. 
Biophys. Acta 620, 18-23. 
[ 19) Hwang, D. H. (1980) Prostaglandins Med. 5,163-173. 
[ 201 Etienne, J., Grtiber, A. and Polonovski, J. (1980) 
Biochim. Biophys. Acta 619,693-698. 
289 
